These results suggest that among all ligands tested, TLR7 agonists may inhibit growth of AML cell lines (partially due to cell cycle blockade and apoptosis induction) as well as induce differentiation on the remaining viable cell population. The gene discussed is TLR7; the disease is acute myeloid leukemia.